Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59.95 TRY | +0.50% | -7.77% | +53.25% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 16.5 | 66.01 | 179.5 | 407.4 | 606 | 1,174 |
Enterprise Value (EV) 1 | 40.56 | 98.16 | 216.7 | 444 | 691.5 | 1,404 |
P/E ratio | 18.6 x | 18.1 x | 25.1 x | 13.2 x | 9.6 x | 26.7 x |
Yield | - | - | - | - | 0.5% | - |
Capitalization / Revenue | 0.2 x | 0.7 x | 1.64 x | 2.82 x | 1.93 x | 1.66 x |
EV / Revenue | 0.49 x | 1.05 x | 1.98 x | 3.07 x | 2.21 x | 1.99 x |
EV / EBITDA | 5.08 x | 8.32 x | 11.8 x | 17.7 x | 12 x | 14.7 x |
EV / FCF | -30.4 x | -257 x | -354 x | 83.9 x | -13.8 x | -25.8 x |
FCF Yield | -3.29% | -0.39% | -0.28% | 1.19% | -7.26% | -3.88% |
Price to Book | 0.94 x | 3.42 x | 6.39 x | 6.81 x | 5.03 x | 4.07 x |
Nbr of stocks (in thousands) | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
Reference price 2 | 0.5501 | 2.200 | 5.985 | 13.58 | 20.20 | 39.12 |
Announcement Date | 11/03/19 | 09/03/20 | 11/03/21 | 17/02/22 | 03/03/23 | 26/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 82.17 | 93.87 | 109.4 | 144.5 | 313.6 | 706.3 |
EBITDA 1 | 7.99 | 11.79 | 18.4 | 25.06 | 57.55 | 95.28 |
EBIT 1 | 6.864 | 10.62 | 17.16 | 23.25 | 54.49 | 77.7 |
Operating Margin | 8.35% | 11.32% | 15.69% | 16.09% | 17.38% | 11% |
Earnings before Tax (EBT) 1 | 1.232 | 5.039 | 8.381 | 36.31 | 74.48 | 44.12 |
Net income 1 | 0.8876 | 3.643 | 7.141 | 30.81 | 63.12 | 43.91 |
Net margin | 1.08% | 3.88% | 6.53% | 21.33% | 20.13% | 6.22% |
EPS 2 | 0.0296 | 0.1214 | 0.2380 | 1.027 | 2.104 | 1.464 |
Free Cash Flow 1 | -1.334 | -0.3816 | -0.6115 | 5.294 | -50.24 | -54.52 |
FCF margin | -1.62% | -0.41% | -0.56% | 3.66% | -16.02% | -7.72% |
FCF Conversion (EBITDA) | - | - | - | 21.12% | - | - |
FCF Conversion (Net income) | - | - | - | 17.18% | - | - |
Dividend per Share | - | - | - | - | 0.1000 | - |
Announcement Date | 11/03/19 | 09/03/20 | 11/03/21 | 17/02/22 | 03/03/23 | 26/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 24.1 | 32.2 | 37.1 | 36.6 | 85.5 | 231 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.011 x | 2.726 x | 2.019 x | 1.46 x | 1.486 x | 2.42 x |
Free Cash Flow 1 | -1.33 | -0.38 | -0.61 | 5.29 | -50.2 | -54.5 |
ROE (net income / shareholders' equity) | 5.51% | 20% | 29.9% | 70.2% | 69.6% | 16.3% |
ROA (Net income/ Total Assets) | 6.16% | 7.98% | 9.56% | 8.8% | 12.3% | 7.1% |
Assets 1 | 14.42 | 45.67 | 74.69 | 350.3 | 514.2 | 618 |
Book Value Per Share 2 | 0.5800 | 0.6400 | 0.9400 | 2.000 | 4.010 | 9.600 |
Cash Flow per Share 2 | 0.0200 | 0.2000 | 1.040 | 1.380 | 1.300 | 0.8500 |
Capex 1 | 5.44 | 4.25 | 5.64 | 4.96 | 13.6 | 53 |
Capex / Sales | 6.62% | 4.52% | 5.16% | 3.43% | 4.32% | 7.5% |
Announcement Date | 11/03/19 | 09/03/20 | 11/03/21 | 17/02/22 | 03/03/23 | 26/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+53.25% | 55.6M | |
+3.18% | 104B | |
-8.02% | 62.39B | |
+72.86% | 48.95B | |
+15.97% | 39.58B | |
+2.75% | 32.08B | |
+11.85% | 20.22B | |
+11.78% | 16.86B | |
+14.58% | 14.88B | |
+0.77% | 13.99B |
- Stock Market
- Equities
- SANFM Stock
- Financials Sanifoam Sünger Sanayi ve Ticaret